Patents by Inventor Stuart Armstrong

Stuart Armstrong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10919944
    Abstract: The present invention relates to vaccines comprising a ShK domain of a filarial nematode protein. These vaccines may be used for the prevention and/or treatment of filarial nematode infections. The invention also relates to novel proteins comprising a ShK domain of a filarial nematode protein and pharmaceutical compositions. The invention may be used for the prevention and/or treatment of filarial nematode infections in canine subjects, and also in human subjects.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: February 16, 2021
    Assignees: The University of Liverpool, Edinburgh University
    Inventors: Ben Makepeace, David Taylor, Simon Babayan, Stuart Armstrong, Mark Blaxter
  • Publication number: 20180355002
    Abstract: The present invention relates to vaccines comprising a ShK domain of a filarial nematode protein. These vaccines may be used for die prevention and/or treatment of filarial nematode infections. The invention also relates to novel proteins comprising a ShK domain of a filarial nematode protein and pharmaceutical compositions. The invention may be used for the prevention and/or treatment of filarial nematode infections in canine subjects, and also in human subjects.
    Type: Application
    Filed: May 8, 2018
    Publication date: December 13, 2018
    Inventors: Ben Makepeace, David Taylor, Simon Babayan, Stuart Armstrong, Mark Blaxter
  • Patent number: 9994624
    Abstract: The present invention relates to vaccines comprising a ShK domain of a filarial nematode protein. These vaccines may be used for the prevention and/or treatment of filarial nematode infections. The invention also relates to novel proteins comprising a ShK domain of a filarial nematode protein and pharmaceutical compositions. The invention may be used for the prevention and/or treatment of filarial nematode infections in canine subjects, and also in human subjects.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: June 12, 2018
    Assignees: THE UNIVERSITY OF LIVERPOOL, EDINBURGH UNIVERSITY
    Inventors: Ben Makepeace, David Taylor, Simon Babayon, Stuart Armstrong, Mark Blaxter
  • Publication number: 20170051024
    Abstract: The present invention relates to vaccines comprising a ShK domain of a filarial nematode protein. These vaccines may be used for the prevention and/or treatment of filarial nematode infections. The invention also relates to novel proteins comprising a ShK domain of a filarial nematode protein and pharmaceutical compositions. The invention may be used for the prevention and/or treatment of filarial nematode infections in canine subjects, and also in human subjects.
    Type: Application
    Filed: February 11, 2015
    Publication date: February 23, 2017
    Inventors: Ben MAKEPEACE, David TAYLOR, Simon BABAYAN, Stuart ARMSTRONG, Mark BLAXTER
  • Publication number: 20070243372
    Abstract: A two coat adhesive system containing an undercoat having a flexibilizer, a phenolic resin, and an acid; and, a covercoat containing an aqueous phenolic resin, and an aqueous butadiene polymer latex prepared by emulsion polymerization of at least one butadiene monomer in the presence of a polyvinvyl alcohol.
    Type: Application
    Filed: April 13, 2007
    Publication date: October 18, 2007
    Inventors: Douglas Mowrey, James Williams, Stuart Armstrong, Thomas Gaadt
  • Patent number: 5856776
    Abstract: An electricity supply network has plural switching and transformer stations connected together by cables. Each cable has an inner conductor and an outer sheath connected to housings of the stations. A communication system has plural transducers coupled to the cables at the stations. Each of the transducers is located on a side of its respective cable remote from a sheath connection of the respective cable to its station housing. Each transducer is coupled to both the sheath and the conductor of its respective cable.
    Type: Grant
    Filed: September 26, 1996
    Date of Patent: January 5, 1999
    Assignee: Remote Metering Systems, Ltd.
    Inventors: Donald Stuart Armstrong, Nigal John Halse, Paul Martin Moore, Joseph Anthony Wells
  • Patent number: 5475153
    Abstract: A process for the preparation of 4,4'-isopropylidene bis(2,6-dibromophenol), also known as tetrabrombisphenol A, that dramatically reduces the formation of alkyl bromide by-products. Bisphenol A is brominated with a C.sub.3 to C.sub.5 n-alcohol in a water mixture to suppress the formation of alkyl bromides. The bisphenol A is brominated between 15.degree. C. and 25.degree. C. and then heated at a 55.degree. C. to 70.degree. C. to insure bromination is complete. The tetrabrombisphenol A is then filtered from the reaction mixture and dried. Tetrabromobisphenol A produced from this process typically has a melting point of 180.degree. C. or higher, and is typically greater than 98% pure. Hydrogen peroxide is optionally combined with the reactants to reduce the amount of added bromine necessary for the bromination of the tetrabromobisphenol A.
    Type: Grant
    Filed: January 4, 1995
    Date of Patent: December 12, 1995
    Assignee: Great Lakes Chemical Corp.
    Inventor: Stuart Armstrong
  • Patent number: 4665086
    Abstract: Alleviating the effects of disturbances in circadian rhythms using melatonin.
    Type: Grant
    Filed: September 26, 1985
    Date of Patent: May 12, 1987
    Assignee: Monash University
    Inventors: Roger V. Short, Stuart Armstrong
  • Patent number: 4600723
    Abstract: Disturbances in circadian rhythms of bodily performance and function, as may occur for example in transfer of work patterns from day to night-shift, or rapid crossing of several time zones in an aircraft ("jet lag") are treated by administration of melatonin. Alleviation or prevention of ill effects associated with disturbance of circadian rhythms is achieved by administration of melatonin in specified ways which are varied to suit particular needs and circumstances.
    Type: Grant
    Filed: May 18, 1984
    Date of Patent: July 15, 1986
    Assignee: Monash University
    Inventors: Roger V. Short, Stuart Armstrong